The shares of Cross Country Healthcare, Inc. (CCRN), a technology-driven healthcare workforce solutions company, were surging by more than 28% after the company announced it had entered into a definitive agreement to be acquired by Knox Lane, an investment firm.
Under the terms of the agreement, Knox Lane will acquire Cross Country Healthcare common stock for $13.25 per share in an all-cash transaction valued at $437 million.
The transaction is expected to close in the third quarter of 2026, subject to customary closing conditions.
Upon transaction completion, Cross Country Healthcare will become a privately held company in Knox Lane's portfolio and will cease trading on the Nasdaq.
BofA Securities is serving as the exclusive financial advisor to Cross Country Healthcare, and Davis Polk & Wardwell LLP is serving as legal counsel.
CCRN has traded between $7.43 and $14.99 over the last year. The stock closed Wednesday's trade at $10.11, down 5.25%.
In the pre-market, CCRN is up 28.87% at $13.03.
For more such news For More Such Biotech Stock News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.